Literature DB >> 28089678

Reduced effects of age on dopamine D2 receptor levels in physically active adults.

Linh C Dang1, Jaime J Castrellon2, Scott F Perkins2, Nam T Le3, Ronald L Cowan4, David H Zald5, Gregory R Samanez-Larkin6.   

Abstract

Physical activity has been shown to ameliorate dopaminergic degeneration in non-human animal models. However, the effects of regular physical activity on normal age-related changes in dopamine function in humans are unknown. Here we present cross-sectional data from forty-four healthy human subjects between 23 and 80 years old, showing that typical age-related dopamine D2 receptor loss, assessed with PET [18F]fallypride, was significantly reduced in physically active adults compared to less active adults.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Dopamine; Physical activity

Mesh：

Substances：

Year:  2017        PMID： 28089678      PMCID： PMC5344739          DOI： 10.1016/j.neuroimage.2017.01.018

Source DB:  PubMed          Journal:  Neuroimage        ISSN： 1053-8119            Impact factor:   6.556


  39 in total

Review 1.  The National Blueprint Consensus Conference summary report: strategic priorities for increasing physical activity among adults aged >or=50.

Authors:  Lisa Sheppard; Jane Senior; Chae Hee Park; Robin Mockenhaupt; Wojtek Chodzko-Zajko; Terry Bazzarre
Journal:  Am J Prev Med       Date:  2003-10       Impact factor: 5.043

2.  Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Authors:  Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil
Journal:  Synapse       Date:  2002-12-01       Impact factor: 2.562

3.  Prediction of VO2max with daily step counts for Japanese adult women.

Authors:  Zhen-Bo Cao; Nobuyuki Miyatake; Mitsuru Higuchi; Kazuko Ishikawa-Takata; Motohiko Miyachi; Izumi Tabata
Journal:  Eur J Appl Physiol       Date:  2008-11-05       Impact factor: 3.078

4.  Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.

Authors:  Lawrence S Kegeles; Mark Slifstein; Xiaoyan Xu; Nina Urban; Judy L Thompson; Tiffany Moadel; Jill M Harkavy-Friedman; Roberto Gil; Marc Laruelle; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2010-07-31       Impact factor: 13.382

5.  Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.

Authors:  Paul Cumming; Guoming Xiong; Christian la Fougère; Axel Rominger; Peter Bartenstein; Hans-Georg Buchholz; Markus Piel; Frank Rösch; Gerhard Gründer; Ingo Vernaleken
Journal:  Synapse       Date:  2013-01-12       Impact factor: 2.562

Review 6.  Are dopaminergic neurons selectively vulnerable to Parkinson's disease?

Authors:  Y Agid; M Ruberg; F Javoy-Agid; E Hirsch; R Raisman-Vozari; S Vyas; B Faucheux; P Michel; A Kastner; V Blanchard
Journal:  Adv Neurol       Date:  1993

7.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

Review 8.  The correlative triad among aging, dopamine, and cognition: current status and future prospects.

Authors:  Lars Bäckman; Lars Nyberg; Ulman Lindenberger; Shu-Chen Li; Lars Farde
Journal:  Neurosci Biobehav Rev       Date:  2006-08-09       Impact factor: 8.989

9.  Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.

Authors:  Shih-Ying Wu; Tzu-Feng Wang; Lung Yu; Chauying J Jen; Jih-Ing Chuang; Fong-Sen Wu; Chih-Wei Wu; Yu-Min Kuo
Journal:  Brain Behav Immun       Date:  2010-09-17       Impact factor: 7.217

10.  Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.

Authors:  Shinichiro Nakajima; Fernando Caravaggio; Isabelle Boileau; Jun K Chung; Eric Plitman; Philip Gerretsen; Alan A Wilson; Sylvain Houle; David C Mamo; Ariel Graff-Guerrero
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200
View more
  11 in total

1.  Differential regional decline in dopamine receptor availability across adulthood: Linear and nonlinear effects of age.

Authors:  Kendra L Seaman; Christopher T Smith; Eric J Juarez; Linh C Dang; Jaime J Castrellon; Leah L Burgess; M Danica San Juan; Paul M Kundzicz; Ronald L Cowan; David H Zald; Gregory R Samanez-Larkin
Journal:  Hum Brain Mapp       Date:  2019-04-01       Impact factor: 5.038

Review 2.  Age-related variability in decision-making: Insights from neurochemistry.

Authors:  Anne S Berry; William J Jagust; Ming Hsu
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

3.  Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety.

Authors:  Anne S Berry; Robert L White; Daniella J Furman; Jenna R Naskolnakorn; Vyoma D Shah; Mark D'Esposito; William J Jagust
Journal:  J Neurosci       Date:  2019-02-08       Impact factor: 6.167

4.  Elevated Dopamine Synthesis as a Mechanism of Cognitive Resilience in Aging.

Authors:  Claire J Ciampa; Jourdan H Parent; Molly R Lapoint; Kaitlin N Swinnerton; Morgan M Taylor; Victoria R Tennant; A J Whitman; William J Jagust; Anne S Berry
Journal:  Cereb Cortex       Date:  2022-06-16       Impact factor: 4.861

5.  Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; Paul A Newhouse; David H Zald
Journal:  eNeuro       Date:  2017-09-18

6.  Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Authors:  Anne S Berry; Vyoma D Shah; Daniella J Furman; Robert L White; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Mark D'Esposito; William J Jagust
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

7.  Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.

Authors:  Christopher T Smith; Jennifer L Crawford; Linh C Dang; Kendra L Seaman; M Danica San Juan; Aishwarya Vijay; Daniel T Katz; David Matuskey; Ronald L Cowan; Evan D Morris; David H Zald; Gregory R Samanez-Larkin
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-01       Impact factor: 6.200

8.  Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward.

Authors:  Rui Zhang; Peter Manza; Dardo Tomasi; Sung Won Kim; Ehsan Shokri-Kojori; Sukru B Demiral; Danielle S Kroll; Dana E Feldman; Katherine L McPherson; Catherine L Biesecker; Gene-Jack Wang; Nora D Volkow
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

9.  [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.

Authors:  Adam J Stark; Christopher T Smith; Kalen J Petersen; Paula Trujillo; Nelleke C van Wouwe; Manus J Donahue; Robert M Kessler; Ariel Y Deutch; David H Zald; Daniel O Claassen
Journal:  Neuroimage Clin       Date:  2018-02-10       Impact factor: 4.881

10.  To Do or Not to Do: Dopamine, Affordability and the Economics of Opportunity.

Authors:  Jeff A Beeler; Devry Mourra
Journal:  Front Integr Neurosci       Date:  2018-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.